Brief: Promore Pharma Q4 Operating Loss Widens To SEK 9.4 Mln
Feb 18 (Reuters) - Promore Pharma AB PROMO.ST :
* Q4 OPERATING LOSS FOR PERIOD WAS 9.4 (-6.5) MSEK
Source text for Eikon: ID:nWkrb3JY66
Further company coverage: PROMO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality